CSL Behring – 'The Biggest Company Nobody Has Ever Heard Of' – Raises Its Voice

CEO Paul Perreault tells 'The Pink Sheet' that flu business from Novartis, hemophilia drugs approaching approval, and pipeline blockbuster to prevent secondary heart attacks will transform profile of Australian biopharma.